Webinar: Tryp Therapeutics: Leading the next wave of psychedelic drugs beyond mental health

Webinar: Tryp Therapeutics: Leading the next wave of psychedelic drugs beyond mental health

In a recent webinar, we were joined by Tryp Therapeutics’ Chairman & CEO Greg McKee, President & Chief Scientific Officer Jim Gilligan, and CFO Luke Hayes pursuing psilocybin’s potential to transform the treatment of chronic pain and other medical conditions. The presentation includes an overview of the company, the indications, and how theyare leading the next wave of psychedelics beyond mental health.

See more at: https://www.edisongroup.com/edison-tv/


You may also be interested in these:

Investment Companies

IP Group - executive interview

Investment Companies

Oakley Capital Investments – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free